Mucopolysaccharidosis type IIID: 12 new patients and 15 novel mutations
- PMID: 20232353
- DOI: 10.1002/humu.21234
Mucopolysaccharidosis type IIID: 12 new patients and 15 novel mutations
Abstract
Mucopolysaccharidosis III D (Sanfilippo disease type D, MPS IIID) is a rare autosomal recessive lysosomal storage disorder previously described in only 20 patients. MPS IIID is caused by a deficiency of N-acetylglucosamine-6-sulphate sulphatase (GNS), one of the enzymes required for the degradation of heparan sulphate. So far only seven mutations in the GNS gene have been reported. The clinical phenotype of 12 new MPS IIID patients from 10 families was studied. Mutation analysis of GNS was performed in 16 patients (14 index cases). Clinical signs and symptoms of the MPS IIID patients appeared to be similar to previously described patients with MPS III. Early development was normal with onset of behavioral problems around the age of 4 years, followed by developmental stagnation, deterioration of verbal communication and subsequent deterioration of motor functions. Sequence analysis of the coding regions of the gene encoding GNS (GNS) resulted in the identification of 15 novel mutations: 3 missense mutations, 1 nonsense mutation, 4 splice site mutations, 3 frame shift mutations, 3 large deletions and 1 in-frame small deletion. They include the first missense mutations and a relatively high proportion of large rearrangements, which warrants the inclusion of quantitative techniques in routine mutation screening of the GNS gene.
(c) 2010 Wiley-Liss, Inc.
Similar articles
-
Sanfilippo syndrome type D: natural history and identification of 3 novel mutations in the GNS Gene.Arch Neurol. 2007 Nov;64(11):1629-34. doi: 10.1001/archneur.64.11.1629. Arch Neurol. 2007. PMID: 17998446
-
Genomic basis of mucopolysaccharidosis type IIID (MIM 252940) revealed by sequencing of GNS encoding N-acetylglucosamine-6-sulfatase.Genomics. 2003 Jan;81(1):1-5. doi: 10.1016/s0888-7543(02)00014-9. Genomics. 2003. PMID: 12573255
-
A novel loss-of-function mutation in the GNS gene causes Sanfilippo syndrome type D.Genet Couns. 2009;20(2):133-9. Genet Couns. 2009. PMID: 19650410
-
Sanfilippo syndrome: a mini-review.J Inherit Metab Dis. 2008 Apr;31(2):240-52. doi: 10.1007/s10545-008-0838-5. Epub 2008 Apr 4. J Inherit Metab Dis. 2008. PMID: 18392742 Review.
-
Molecular genetics of mucopolysaccharidosis type IIIA and IIIB: Diagnostic, clinical, and biological implications.Hum Mutat. 2001 Oct;18(4):264-81. doi: 10.1002/humu.1189. Hum Mutat. 2001. PMID: 11668611 Review.
Cited by
-
CRISPR/Cas9 technology in the modeling of and treatment of mucopolysaccharidosis.Biochem Biophys Rep. 2024 Jul 1;39:101771. doi: 10.1016/j.bbrep.2024.101771. eCollection 2024 Sep. Biochem Biophys Rep. 2024. PMID: 39044769 Free PMC article. Review.
-
Molecular Bases of Neurodegeneration and Cognitive Decline, the Major Burden of Sanfilippo Disease.J Clin Med. 2020 Jan 27;9(2):344. doi: 10.3390/jcm9020344. J Clin Med. 2020. PMID: 32012694 Free PMC article. Review.
-
Deciphering the Kidney Matrisome: Identification and Quantification of Renal Extracellular Matrix Proteins in Healthy Mice.Int J Mol Sci. 2023 Feb 1;24(3):2827. doi: 10.3390/ijms24032827. Int J Mol Sci. 2023. PMID: 36769148 Free PMC article.
-
Heparan sulfate derived disaccharides in plasma and total urinary excretion of glycosaminoglycans correlate with disease severity in Sanfilippo disease.J Inherit Metab Dis. 2013 Mar;36(2):271-9. doi: 10.1007/s10545-012-9535-5. Epub 2012 Sep 12. J Inherit Metab Dis. 2013. PMID: 22968582
-
Unveiling metabolic remodeling in mucopolysaccharidosis type III through integrative metabolomics and pathway analysis.J Transl Med. 2018 Sep 4;16(1):248. doi: 10.1186/s12967-018-1625-1. J Transl Med. 2018. PMID: 30180851 Free PMC article.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases